SBI AA 3-5 Y/ CH0035278479
ST235Y2024-05-30 5:15:00 PM | Chg. +0.0700 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
1.6700XXP | +4.38% | 1.6100 | 1.6700 | 1.6100 | 1.6000 |
GlobeNewswire
8:14 AM
STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire
8:00 AM
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
7:30 AM
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
7:05 AM
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
7:05 AM
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
7:00 AM
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
7:00 AM
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
7:00 AM
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
6:08 AM
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
5:00 AM
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options